Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Bjorn Gudbjornsson

Prof

University of Iceland

Iceland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Immunology

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (17)

Sigurður Yngvi Kristinsson

ICELAND

View details

Sella Aarrestad Provan

Diakonhjemmet Hospital

NORWAY

View details

Kim Hørslev-Petersen

Professor

University of Southern Denmark

DENMARK

View details

Gareth Jones

University of Aberdeen

UNITED KINGDOM

View details

Till Uhlig

Professor

University of Oslo

NORWAY

View details

Thorvardur Jon Love

Professor

University of Iceland

ICELAND

View details

Lotta Ljung

Karolinska Institutet

SWEDEN

View details

Kristina Lend

Karolinska Institutet

SWEDEN

View details

Daniela Di Giuseppe

Karolinska University Hospital

SWEDEN

View details

Benedicte Delcoigne

Karolinska Institutet

SWEDEN

View details

Meliha Kapetanovic

adj professor

Lund University

SWEDEN

View details

Adrian Ciurea

Deputy Head of Department

University Hospital of Zurich

SWITZERLAND

View details

Isabel Tapia-Paez

Karolinska Institutet

SWEDEN

View details

Lars Iversen

VIP, Professor

Aarhus University

DENMARK

View details

Gary Macfarlane

Chair (Clinical) in Epidemiology

University of Aberdeen

UNITED KINGDOM

View details

sailan wang

Karolinska Institutet

SWEDEN

View details

Alexis Ogdie

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bjorn Gudbjornsson

Research Interests

Make your next move.

Explore related searches

Articles (12)

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis

Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis: A Swedish Nationwide Registry Study

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis

Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study

Familial risk and phenotypic variation of sarcoidosis in the Icelandic population

Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans.

Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries

Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study

Comment on: Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen: reply

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen.

Collaborators (17)

Sigurður Yngvi Kristinsson

Sella Aarrestad Provan

Kim Hørslev-Petersen

Gareth Jones

Till Uhlig

Thorvardur Jon Love

Lotta Ljung

Kristina Lend

Daniela Di Giuseppe

Benedicte Delcoigne

Meliha Kapetanovic

Adrian Ciurea

Isabel Tapia-Paez

Lars Iversen

Gary Macfarlane

sailan wang

Alexis Ogdie

Make your next move.